Whalesbook
### The Growth Engine Under Scrutiny
The Indian Electronics Manufacturing Services (EMS) industry is experiencing rapid expansion, supported by strong domestic demand, government policy, and global shifts in manufacturing. HDFC Securities projects the sector will achieve a 27% compound annual growth rate (CAGR) from FY24 to FY29, following a strong 24% CAGR from FY19 to FY24. Growth drivers include production-linked incentives (PLI), global manufacturers looking to diversify supply chains away from China, rising domestic consumption, and increased outsourcing of manufacturing.
Despite this growth, market enthusiasm is tempered by high valuations and mixed stock performance. JP Morgan noted significant stock drops for Kaynes Technology (-35%) and Dixon Technologies (-29%) after September results, though Syrma SGS Technology, Amber Enterprises, and Avalon Technologies showed more stability. Analyst views differ: Jefferies rates Amber, Syrma, and Kaynes as 'Buy', but Dixon as 'Hold'. JP Morgan keeps Syrma SGS as a top pick and upgrades Amber Enterprises to 'Overweight'. Valuations show this divergence: Dixon and Kaynes trade at high multiples, with Dixon's FY27e P/E near 70x and Kaynes's around 65x. Syrma SGS's P/E is about 52.33x, while Amber Enterprises has a more moderate valuation. These high prices require strong execution to meet investor expectations.
### The Component Conundrum and Margin Squeeze
The EMS sector's future is increasingly shaped by a shift from basic assembly to making higher-value components. Schemes like the Electronics Component Manufacturing Scheme (ECMS) are key to this change. Amber Enterprises and Syrma SGS Technology have applied for PCB manufacturing under ECMS. Amber is seeking multi-layer and HDI PCBs through a joint venture, while Dixon Technologies is boosting its component manufacturing, including camera and display modules. This strategy aims to increase local value creation and reduce India's strong dependence on imported components, an ongoing challenge.
However, the EMS business model itself creates margin pressures. Components usually make up about 70% of total product cost. This leaves EMS firms earning revenue from assembly, testing, and logistics, usually with low margins. This puts EMS firms on the 'Smile Curve', earning less than brands or key component makers. Relying on a 'turnkey' model, where EMS firms source components, adds inventory and supplier risks, leaving them open to price jumps and delays. Geopolitical tensions have also raised concerns about global chip supply disruptions, affecting the cost and supply of vital parts.
### The Bear Case: Valuations, Volatility, and Vulnerabilities
High valuations across major players, including Syrma SGS (46.83x FY27e P/E) and Kaynes Technology (59.91x FY27e P/E), pose a significant risk if growth or profit targets are missed. JP Morgan's analysis showed sharp stock drops for Kaynes and Dixon, highlighting sector volatility. India's ongoing reliance on imported components, especially from China, is a key vulnerability, leaving the industry open to global supply chain disruptions, geopolitical risks, and price swings. Smaller manufacturers face hurdles meeting minimum order quantities (MOQs), getting credit, and building supplier trust, leading to unstable pricing and tight margins.
Additionally, the drive for advanced manufacturing demands significant capital spending. For example, analysts estimate capital expenditure for Amber, Syrma, Dixon, and Kaynes Technology at ₹9,000 crore for FY26–28, planned early to boost factory use. This heavy investment cycle, combined with the low margins typical in assembly, creates a risk if demand or execution falters. Growing focus on ESG factors and climate-related disruptions also add complexity and risk to supply chain management.
### Outlook: Policy Push Meets Execution Reality
Looking ahead, the Indian EMS sector benefits from continued policy support, including increased funding for the ECMS scheme, now set at ₹40,000 crore. The government aims to make India a major component manufacturer and attract significant investment. JP Morgan forecasts revenue growth above 20% for most EMS players through FY28. Analysts expect that as companies integrate more backward in the supply chain, costs will drop, and exports will grow.
However, whether current growth rates and high valuations can be sustained depends on the industry's ability to turn policy support and market opportunities into better profits and higher margins. The shift to higher-value manufacturing, while promising, requires large investments and faces execution challenges. Investors will watch closely how these companies manage complex component sourcing, control costs, and meet ambitious growth targets amid a changing global economy and geopolitical situation.